Technetium-99m-sestamibi uptake in myeloma.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 8683291.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
A number of reports describe how 99mTc-sestamibi detects benign and malignant primary and metastatic tumors. We report abnormal 99mTc-sestamibi uptake in nine sites in a 53-yr-old patient with histologically and biochemically proven IgG kappa-secreting myeloma. The 99mTc-sestamibi study was undertaken for an unrelated hyperparathyroidism.
Medical subject headings
- Multiple Myeloma
- Technetium Tc 99m Sestamibi